ANTIEMETIC ACTIVITY OF NEUROKININ NK1 RECEPTOR ANTAGONISTS IS MEDIATED CENTRALLY IN THE FERRET

ANTIEMETIC ACTIVITY OF NEUROKININ NK1 RECEPTOR ANTAGONISTS IS MEDIATED CENTRALLY IN THE FERRET

Detalhes bibliográficos
Principais autores:	Gardner, C, Bountra, C, Bunce, K, Dale, T, Jordan, C, Twissell, D, Ward, P
Formato:	Journal article
Publicado em:	1994

Registros relacionados

Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets.
por: Bountra, C, et al.
Publicado em: (1993)

The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040.
por: Gardner, C, et al.
Publicado em: (1995)

Effect of the neurokinin 1 (NK1) receptor antagonist GR205171 on adjuvant-induced inflammatory pain in the rat
por: Clayton, N, et al.
Publicado em: (1997)

THE ANTIEMETIC ACTION OF THE NOVEL 5-HT3 RECEPTOR ANTAGONIST L-683,877 IN THE FERRET
por: Tattersall, F, et al.
Publicado em: (1990)

The neurokinin 1 (NK) receptor antagonist GR205171 reduces carrageenan-evoked Fos-like immunoreactivity in the rat lumbar spinal cord
por: Smith, E, et al.
Publicado em: (1997)

Towards understanding the aetiology and pathophysiology of the emetic reflex: novel approaches to antiemetic drugs.
por: Bountra, C, et al.
Publicado em: (1996)

The effects of ibuprofen and the neurokinin-1 receptor antagonist GR205171A on Fos expression in the ferret trigeminal nucleus following tooth pulp stimulation.
por: Worsley, M, et al.
Publicado em: (2008)

The effects of inflammation and the neurokinin-1 receptor antagonist GR205171A on fos expression in the ferret trigeminal nucleus following tooth pulp stimulation.
por: Worsley, M, et al.
Publicado em: (2003)

Neurokinin-1 receptor antagonists as novel antidepressants: trials and tribulations.
por: Hafizi, S, et al.
Publicado em: (2007)

Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation.
por: Jones, S, et al.
Publicado em: (2008)

The vomiting reflex and the role of 5-HT3 receptors.
por: Freeman, A, et al.
Publicado em: (1993)

Changes in spinal cord neuropeptides in the adjuvant model of chronic inflammatory hyperalgesia in the presence and absence of the NK1 receptor antagonist GR205171
por: Cougnon-Aptel, N, et al.
Publicado em: (1999)

Discovery of an orally bioavailable NK1 receptor antagonist, (2S,3S)-(2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine (GR203040), with potent antiemetic activity.
por: Ward, P, et al.
Publicado em: (1995)

Neurokinin-1 receptors on the afferents to the raphe
por: Hafizi, S, et al.
Publicado em: (2005)

Neurokinin-1 receptors on the afferents to the raphe
por: Hafizi, S, et al.
Publicado em: (2005)

THE ROLE OF NK-3 AND NK-4 RECEPTORS IN THE MEDIATION OF RECIPROCAL HINDLIMB SCRATCHING INDUCED BY TACHYKININ RECEPTOR AGONISTS
por: Dourish, C, et al.
Publicado em: (1988)

THE ROLE OF NEUROKININ AND METABOTROPIC GLUTAMATE RECEPTORS IN THERMAL AND MECHANICAL PAW WITHDRAWAL RESPONSES IN NORMAL AND CARRAGEENAN-TREATED RATS
por: Young, M, et al.
Publicado em: (1995)

The tachykinin NK3 receptor antagonist SR142801 blocks the behavioral effects of cocaine in marmoset monkeys.
por: De Souza Silva, MA, et al.
Publicado em: (2006)

Cognitive performance in neurokinin 3 receptor knockout mice.
por: Nordquist, R, et al.
Publicado em: (2008)

Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580.
por: Rupniak, N, et al.
Publicado em: (1993)

Neurokinin3 receptor modulation of the behavioral and neurochemical effects of cocaine in rats and monkeys.
por: Silva, M, et al.
Publicado em: (2008)

Brain neurokinin-1 receptors in depression and interactions with the serotonin system
por: Hafizi, S
Publicado em: (2009)

The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats.
por: Stoessl, A, et al.
Publicado em: (1988)

Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.
por: O'Neill, M, et al.
Publicado em: (1991)

The NK1 receptor antagonist N-acetyl-l-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model
por: Thornton, E, et al.
Publicado em: (2014)

Evidence for the differential co-localization of neurokinin-1 receptors with 5-HT receptor subtypes in rat forebrain.
por: Hafizi, S, et al.
Publicado em: (2012)

A Role for Peripheral Tachykinins and the Neurokinin 1 Receptor in the Regulation of Platelet Thrombus Formation
por: Jones, S, et al.
Publicado em: (2008)

Evaluation of the effect of chronic antidepressant treatment on neurokinin-1 receptor expression in the rat brain.
por: Sartori, S, et al.
Publicado em: (2004)

The effect of inflammation on Fos expression in the ferret trigeminal nucleus.
por: Worsley, M, et al.
Publicado em: (2007)

Ibuprofen with or without an antiemetic for acute migraine headaches in adults
por: Rabbie, R, et al.
Publicado em: (2013)

Aspirin with or without an antiemetic for acute migraine headaches in adults.
por: Kirthi, V, et al.
Publicado em: (2013)

Diclofenac with or without an antiemetic for acute migraine headaches in adults.
por: Derry, S, et al.
Publicado em: (2013)

Aspirin with or without an antiemetic for acute migraine headaches in adults.
por: Kirthi, V, et al.
Publicado em: (2013)

Ibuprofen with or without an antiemetic for acute migraine headaches in adults.
por: Rabbie, R, et al.
Publicado em: (2010)

Diclofenac with or without an antiemetic for acute migraine headaches in adults.
por: Derry, S, et al.
Publicado em: (2012)

Aspirin with or without an antiemetic for acute migraine headaches in adults.
por: Kirthi, V, et al.
Publicado em: (2010)

Naproxen with or without an antiemetic for acute migraine headaches in adults
por: Law, S, et al.
Publicado em: (2013)

A study of NK-3 tachykinin receptors
por: Guard, S, et al.
Publicado em: (1989)

Neurokinin-1 receptor antagonism by SR140333: enhanced in vivo ACh in the hippocampus and promnestic post-trial effects.
por: Kart, E, et al.
Publicado em: (2004)

Review article: the therapeutic potential of 5-HT3 receptor antagonists in the treatment of irritable bowel syndrome.
por: Humphrey, P, et al.
Publicado em: (1999)